Patients were evaluated at baseline and selected intervals (1 and 3 month) for the following efficacy variables: The International Prostate Symptom Score (IPSS), quality of life (QoL) - related symptoms, International Index of Erectile Function score, peak urine flow rate, and prostate volume (on ultrasound).